GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Sep 2002 12:48 PM
RNS
Director Shareholding
09 Sep 2002 04:39 PM
RNS
Director Shareholding
09 Sep 2002 04:12 PM
RNS
Director Shareholding
06 Sep 2002 05:21 PM
RNS
Director Shrhldg-Replacement
06 Sep 2002 03:56 PM
RNS
Director Shareholding
05 Sep 2002 04:51 PM
RNS
Purchase of Own Securities
03 Sep 2002 03:59 PM
RNS
Director Shareholding
03 Sep 2002 03:55 PM
RNS
Director Shareholding
02 Sep 2002 05:37 PM
RNS
Director Shareholding
02 Sep 2002 05:33 PM
RNS
Director Shareholding
30 Aug 2002 04:26 PM
RNS
Director Shareholding
28 Aug 2002 03:43 PM
RNS
Director Shareholding
27 Aug 2002 05:20 PM
RNS
Purchase of Own Securities
27 Aug 2002 04:58 PM
RNS
Director Shareholding
23 Aug 2002 04:47 PM
RNS
Director Shareholding
21 Aug 2002 05:02 PM
RNS
Purchase of Own Securities
20 Aug 2002 06:18 PM
RNS
Director Shareholding
19 Aug 2002 05:45 PM
RNS
Director Shareholding
19 Aug 2002 01:04 PM
RNS
Director Shareholding
16 Aug 2002 05:14 PM
RNS
Purchase of Own Securities
14 Aug 2002 02:59 PM
RNS
Director Shareholding
12 Aug 2002 03:19 PM
RNS
Director Shareholding
12 Aug 2002 03:11 PM
RNS
Director Shareholding
12 Aug 2002 03:08 PM
RNS
Director Shareholding
07 Aug 2002 05:10 PM
RNS
Purchase of Own Securities
07 Aug 2002 03:25 PM
RNS
Doc re. Half Year Report
06 Aug 2002 04:39 PM
RNS
Director Shareholding
06 Aug 2002 04:36 PM
RNS
Director Shareholding
06 Aug 2002 04:31 PM
RNS
Director Shareholding
05 Aug 2002 06:16 PM
RNS
Director Shareholding
05 Aug 2002 06:13 PM
RNS
Director Shareholding
05 Aug 2002 06:10 PM
RNS
Director Shareholding
02 Aug 2002 05:03 PM
RNS
Purchase of Own Securities
02 Aug 2002 04:20 PM
RNS
Director Shareholding
29 Jul 2002 03:32 PM
RNS
Director Shareholding
29 Jul 2002 11:24 AM
RNS
Director Shareholding
24 Jul 2002 12:30 PM
RNS
Interim Results
24 Jul 2002 07:00 AM
RNS
FDA letter vardenafil
23 Jul 2002 04:24 PM
RNS
Director Shareholding
23 Jul 2002 04:23 PM
RNS
Director Shareholding
22 Jul 2002 05:48 PM
RNS
Director Shareholding
22 Jul 2002 03:17 PM
RNS
Director Shareholding
16 Jul 2002 03:52 PM
RNS
Director Shareholding
15 Jul 2002 05:30 PM
RNS
Director Shareholding
15 Jul 2002 05:19 PM
RNS
Director Shareholding
15 Jul 2002 05:16 PM
RNS
Director Shareholding
12 Jul 2002 03:48 PM
RNS
Director Shareholding
09 Jul 2002 05:14 PM
RNS
Director Shareholding
09 Jul 2002 05:09 PM
RNS
Director Shareholding
08 Jul 2002 05:12 PM
RNS
Director Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings